134759
1,2,3,6-四氢吡啶
97%
别名:
Δ3-哌啶, 1,2,5,6-四氢吡啶, 3,6-二氢-2H-吡啶
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C5H9N
化学文摘社编号:
分子量:
83.13
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
211-766-2
MDL number:
Assay:
97%
Form:
liquid
InChI key
FTAHXMZRJCZXDL-UHFFFAOYSA-N
InChI
1S/C5H9N/c1-2-4-6-5-3-1/h1-2,6H,3-5H2
SMILES string
C1CC=CCN1
assay
97%
form
liquid
refractive index
n20/D 1.48 (lit.)
bp
108 °C (lit.)
mp
−48 °C (lit.)
density
0.911 g/mL at 25 °C (lit.)
Quality Level
Application
用于形成烯-内型-螺环铵叶立德，再通过 [2,3]-σ 迁移重排形成吡咯并氮杂环庚烷酮和氧氮杂环庚烷酮类化合物。
Packaging
无底玻璃瓶。内含物装在插入的融合锥内。
signalword
Danger
hcodes
Hazard Classifications
Eye Irrit. 2 - Flam. Liq. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
3 - Flammable liquids
wgk
WGK 3
flash_point_f
60.8 °F - closed cup
flash_point_c
16 °C - closed cup
ppe
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
法规信息
危险化学品
此项目有
Edward Roberts et al.
Organic letters, 7(10), 2075-2078 (2005-05-07)
The first examples of sigmatropic rearrangements of ene-endo-spirocyclic, tetrahydropyridine-derived ammonium ylids are reported. Thus, spiro[6.7]-ylids rearrange primarily by a [2,3]-pathway, whereas the analogous [6.6]-ylids rearrange by [1,2]- and [2,3]-mechanisms in roughly equal proportions. This method serves as a rapid entry
Santhosh Sethuramanujam et al.
Journal of neurophysiology, 112(1), 193-203 (2014-04-11)
Glutamate release at bipolar to ganglion cell synapses activates NMDA and AMPA/kainic acid (KA) ionotropic glutamate receptors. Their relative strength determines the output signals of the retina. We found that this balance is tightly regulated by presynaptic inhibition that preferentially
Cyril G Eleftheriou et al.
Molecular vision, 23, 334-345 (2017-07-01)
Retinal dystrophy through outer photoreceptor cell death affects 1 in 2,500 people worldwide with severe impairment of vision in advanced stages of the disease. Optogenetic strategies to restore visual function to animal models of retinal degeneration by introducing photopigments to
Philippe Huot et al.
Neuropharmacology, 97, 306-311 (2015-06-15)
L-3,4-dihydroxyphenylalanine (L-DOPA) is the most effective anti-parkinsonian agent available, but upon chronic administration, patients with Parkinson's disease (PD) experience abnormal involuntary movements, dyskinesia. Modulation of serotonin 1A (5-HT1A) receptors is regarded as an effective way to alleviate dyskinesia, yet this
Zhili Ren et al.
Neuropharmacology, 93, 209-218 (2015-02-15)
Parkinson's disease (PD) is a neurological disorder characterized by degeneration of nigrostriatal dopaminergic (DAergic) system. Present treatment targeting to DAergic system solely ameliorated the symptoms but failed to retard the DAergic neuron degeneration, therefore new therapeutic methods aiming at preventing
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持